Manuel Neuberger
Overview
Explore the profile of Manuel Neuberger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Wenzel M, Borkowetz A, Lieb V, Hoffmann M, Borgmann H, Hofner T, et al.
Urol Oncol
. 2022 Oct;
40(12):538.e7-538.e14.
PMID: 36244915
Objective: Since multiple oncological treatment options in metastatic castration-resistant prostate cancer (mCRPC) are available, optimal sequencing of therapies are under investigation. However, the efficacy of Cabazitaxel (CAB) in fourth and...
22.
Wessels F, Schmitt M, Krieghoff-Henning E, Kather J, Nientiedt M, Kriegmair M, et al.
PLoS One
. 2022 Aug;
17(8):e0272656.
PMID: 35976907
For clear cell renal cell carcinoma (ccRCC) risk-dependent diagnostic and therapeutic algorithms are routinely implemented in clinical practice. Artificial intelligence-based image analysis has the potential to improve outcome prediction and...
23.
Neuberger M, Goly N, Skladny J, Milczynski V, Weiss C, Wessels F, et al.
J Cancer Res Clin Oncol
. 2022 Aug;
149(7):3371-3381.
PMID: 35939112
Purpose: Advances in therapy of metastatic castration-refractory prostate cancer (mCRPC) resulted in more therapeutic options and led to a higher need of predictive/prognostic biomarkers. Systemic inflammatory biomarkers could provide the...
24.
Neuberger M, Skladny J, Goly N, Wessels F, Weiss C, Egen L, et al.
Anticancer Res
. 2022 Mar;
42(4):1911-1918.
PMID: 35347010
Background/aim: To assess the baseline inflammatory markers modified Glasgow Prognostic Score (mGPS), systemic immune-inflammation index (SII), and neutrophile-to-lymphocyte ratio (NLR) as pragmatic tools for predicting response to chemohormonal therapy (docetaxel...
25.
Wessels F, Kuntz S, Krieghoff-Henning E, Schmitt M, Braun V, Worst T, et al.
Minerva Urol Nephrol
. 2022 Mar;
74(5):538-550.
PMID: 35274903
Introduction: Artificial intelligence (AI) has been successfully applied for automatic tumor detection and grading in histopathological image analysis in urologic oncology. The aim of this review was to assess the...
26.
Grune B, Menold H, Lenhart M, Muhlbauer J, Walach M, Waldbillig F, et al.
Urol Int
. 2022 Jan;
107(3):280-287.
PMID: 34999586
Introduction: This study aimed to assess patient compliance with a newly established electronic patient-reported outcome measure (ePROM) system after urologic surgery and to identify influencing factors. Methods: Digital surveys were...
27.
Derigs F, Doryumu S, Tollens F, Norenberg D, Neuberger M, von Hardenberg J, et al.
World J Urol
. 2021 Nov;
40(2):427-433.
PMID: 34825944
Purpose: Magnetic resonance imaging (MRI)/ultrasound-fusion prostate biopsy (FB) comprises multiple steps each of which can cause alterations in targeted biopsy (TB) accuracy leading to false-negative results. The aim was to...
28.
Kowalewski K, Sidoti Abate M, Neuberger M, Kirchner M, Krisam R, Egen L, et al.
BMJ Open
. 2021 Nov;
11(11):e052087.
PMID: 34732486
Introduction: Randomised controlled trials comparing robotic-assisted partial nephrectomy (RAPN) and open PN (OPN) are lacking. Therefore, we aim to report the study protocol and a trial update for a randomised...
29.
Neuberger M, Schmidt L, Wessels F, Linke M, Muller C, Westhoff N, et al.
Support Care Cancer
. 2021 Sep;
30(2):1303-1313.
PMID: 34477972
Objectives: To explore men's onset and burden of lower limb lymphedema (LLL) after radical prostatectomy (RP) with pelvic lymph node dissection (PLND). Patients And Methods: A cross-sectional survey-based study was...
30.
Westhoff N, Anokhin A, Patroi P, Neuberger M, Siegel F, Pfalzgraf D
Urol Int
. 2021 Aug;
106(4):411-418.
PMID: 34333486
Introduction: Screening for and treating asymptomatic bacteriuria (ABU) or administering antibiotic prophylaxis is recommended during ureteral stent and nephrostomy interventions. This study investigates the frequency of postinterventional infectious complications to...